Immunic | VTL - Cash And Equivalent


Immunic reported $186.63M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
BioMarin Pharmaceutical USD 874M 1.35B Jun/2026
Cipla INR 10.18B 2.22B Mar/2026
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 12.43M 78.16M Mar/2026
CSL USD 2.16B 633M Jun/2025
Enanta Pharmaceuticals USD 37.44M 5.14M Dec/2025
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 186.63M 171.15M Mar/2026
Insmed USD 544.76M 37.42M Jun/2026
Omeros USD 1.9M 2.36M Jun/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Quidel USD 123.4M 17M Jun/2026
Ultragenyx Pharmaceutical USD 125M 50M Jun/2026
United Therapeutics USD 1.8B 523.5M Jun/2026